Ally Bridge Group

Investor type

PE / VC

Founded

2013

AUM

$3 000 M

Location

New York, New York, United States

Investment Ticket

$0-1 m

Investment Stage

Seed Series B Series A

Region of investment

North America Europe Asia
Investor profile last updated: 28 August, 2026

Profile

Ally Bridge Group is a global healthcare investment management firm that focuses on high-impact life science innovation. Founded in 2013 by Frank Yu, who serves as the Chief Executive Officer and Chief Investment Officer, the firm operates from offices in New York and Hong Kong. With a team that combines deep scientific knowledge with expertise in mergers and acquisitions, Ally Bridge Group aims to generate superior risk-adjusted returns while addressing unmet medical needs.

The firm invests across the global healthcare industry, utilizing both private equity and public equity strategies. Their investments span various healthcare subsectors, and they seek to deliver returns through a comprehensive understanding of value in both private and public markets. Ally Bridge Group has been involved in over $6 billion of transactions since its inception, showcasing its commitment to impactful investments in the life sciences sector.

Notable investments include Medtronic - medical technology leader, Intercept Pharmaceuticals - biotech innovator, and various companies in the medical devices and digital health sectors. The firm's approach emphasizes synergies between private and public equity platforms, leveraging global insights to secure opportunities in life science innovation.

Industry

Education Edtech Fashion/Beauty Healthcare Services Media and Entertainment Robotics Software HealthTech Biotechnology MedTech

Ally Bridge Group Funds

Name Type
Questionare
Industry
Questionare
Stage
Questionare
Region
Size AUM Launch date
Private Equity Strategy
Venture Capital (VC)
Biotechnology
MedTech
HealthTech
Seed
Series A
North America
Asia
$5-10 m
$80 M
August 2023
Public Equity Strategy
Fund of funds
Biotechnology
MedTech
Pre-seed
Seed
Series A
Series B
Late Stage (Series C+)
North America
South America
Europe
Middle East
Africa
Asia
Australia and others
$5-10 m
$266 M
November 2018

Contacts

Name
Title
Email
avatar
Paresh Kumar Vice President, Biotech Private Equity
Vice President, Biotech Private Equity
p•••@•••
avatar
Alan Chen Partner and Managing Director, Head of Private Equity
Partner and Managing Director, Head of Private Equity
a•••@•••
Upgrade to see contacts
avatar
iol3HjrDBncNZqhO iol3HjrDBncNZqhO
iol3HjrDBncNZqhO
avatar
iol3HjrDBncNZqhO iol3HjrDBncNZqhO
iol3HjrDBncNZqhO
avatar
iol3HjrDBncNZqhO iol3HjrDBncNZqhO
iol3HjrDBncNZqhO
Investment-team contacts for Ally Bridge Group — including verified work emails and LinkedIn profiles — are available to Private Equity List subscribers.
Instant access on the web. Plans from $129/month — see pricing.
Contacts sourced from the firm's website and LinkedIn, re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.

FAQs about Ally Bridge Group

Ally Bridge Group is a venture capital and private equity firm. It backs companies at Seed, Series B and Series A, writing tickets of $0-1 m.
Ally Bridge Group is located in New York, New York, United States.
Ally Bridge Group was founded in 2013.
Ally Bridge Group invests in companies and startups in Education, Edtech, Fashion/Beauty, Healthcare Services, Media and Entertainment, Robotics, Software, HealthTech, Biotechnology, MedTech.
Ally Bridge Group invests in companies and startups in North America, Europe, Asia.
Ally Bridge Group invests in companies and startups at Seed, Series B, Series A.
Ally Bridge Group usually invests $0-1 m on average.
Ally Bridge Group has around $3 000m assets under management.
Ally Bridge Group last fund was created/launched in 2023-08-02
Ally Bridge Group can be reached through its website ally-bridge.com and its LinkedIn page. Its general enquiries address is [email protected]. Cold-mailing a general inbox rarely reaches a partner, so Private Equity List also lists the investment-team contacts for Ally Bridge Group — names, roles, verified work emails and LinkedIn profiles — available on a Pro plan from $129/month (see pricing). Contacts are sourced from the firm's website and LinkedIn and re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.
Yes. Every field on this page — profile, funds, investment criteria, portfolio and investment-team contacts — is available programmatically through the Private Equity List REST API and MCP server, so AI assistants such as Claude and ChatGPT can query Ally Bridge Group directly instead of scraping this page. One subscription covers both the web app and machine access — see API & MCP.
Private Equity List re-verifies investor profiles on a rolling cycle, pulling from the firm's own website and LinkedIn rather than a one-off import. This profile was last updated on 28 August, 2026. Something out of date here? Report it — we re-run that firm within 48h and get back to you.